This is particularly interesting because NTRK1 is a membrane-bound receptor that phosphorylates itself and members of the MAPK pathway [52] and it is already known that it confers resistance to cancer chemotherapy by activating p38 mitogen-activated protein kinase signaling pathways [53, 54], where RIT1 belongs. Here, MAPK14 is linked to cancer.